Reynold Spector Award in Clinical Pharmacology and Translational Medicine
Forecasted
Reynold Spector Award in Clinical Pharmacology and Translational Medicine honors clinical pharmacology researchers and teachers for excellence, recognizing achievements rather than funding proposed projects.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Nomination deadline)
Funding Amounts: Scientific achievement award
Summary: Recognizes excellence in research and/or teaching in clinical pharmacology rather than funding proposed research projects.
Key Information: Candidates must be older than 45 and specialize in clinical pharmacology.
Description
The Reynold Spector Award in Clinical Pharmacology and Translational Medicine is presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET). It recognizes excellence in research and/or teaching in clinical pharmacology. As part of ASPET’s Scientific Achievement Awards, it honors accomplishments rather than supporting a proposed research project.
ASPET established the award in 2014 in recognition of Dr. Spector’s dedication and contributions to clinical pharmacology. The award is supported by an endowment from Dr. Reynold and Mrs. Michiko Spector. It sits within a broader awards program recognizing accomplishments in specific areas of pharmacology and contributions to the discipline generally.
